1. Home
  2. EVR vs EXAS Comparison

EVR vs EXAS Comparison

Compare EVR & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evercore Inc.

EVR

Evercore Inc.

HOLD

Current Price

$331.74

Market Cap

11.7B

Sector

Finance

ML Signal

HOLD

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$101.06

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVR
EXAS
Founded
1995
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7B
11.0B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
EVR
EXAS
Price
$331.74
$101.06
Analyst Decision
Buy
Buy
Analyst Count
9
20
Target Price
$320.11
$76.38
AVG Volume (30 Days)
344.0K
10.3M
Earning Date
10-29-2025
11-03-2025
Dividend Yield
1.01%
N/A
EPS Growth
61.11
N/A
EPS
12.55
N/A
Revenue
$3,542,875,000.00
$3,082,033,000.00
Revenue This Year
$25.39
$19.40
Revenue Next Year
$16.43
$13.51
P/E Ratio
$26.43
N/A
Revenue Growth
27.03
14.47
52 Week Low
$148.63
$38.81
52 Week High
$364.42
$101.87

Technical Indicators

Market Signals
Indicator
EVR
EXAS
Relative Strength Index (RSI) 62.83 89.74
Support Level $310.93 $100.98
Resistance Level $322.82 $101.43
Average True Range (ATR) 11.11 2.25
MACD 3.21 0.53
Stochastic Oscillator 87.16 97.74

Price Performance

Historical Comparison
EVR
EXAS

About EVR Evercore Inc.

Evercore is a leading independent investment banking advisory firm that generates most of its revenue through merger and acquisition and restructuring advisory services, with much smaller capital raising, equities trading, and investment management businesses. Founded in 1995, it has built a reputation for advising on some of the world's largest and most complex transactions. The firm operates globally with a strong presence in the US and Europe, serving corporations, financial sponsors, and government clients. Its business model emphasizes high-touch, conflict-free advice rather than balance sheet lending, allowing it to compete with larger bulge-bracket banks.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: